Clinical trial
Cladribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System Biomarkers in Multiple Sclerosis
NCT03963375 is registered in ClinicalTrials.gov with Gregory Wu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cladribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System Biomarkers in Multiple Sclerosis
- Lead sponsor
- Gregory Wu
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 28, 2019
- Completion date
- May 27, 2025
- Enrollment
- 47 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.